Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Haematologica
|
September 8, 2022
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
Ayalew Tefferi, Amritpal Singh, Naseema Gangat, et al.
Blood Cancer Journal
|
June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
Mayo Clinic Proceedings
|
March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Haematologica
|
February 16, 2023
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
Maymona G Abdelmagid, Aref Al-Kali, Kebede H Begna, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Haematologica
|
December 15, 2022
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm
Naseema Gangat, Rimal Ilyas, Kristen McCullough, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2016
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Haematologica
|
September 8, 2022
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival
Ayalew Tefferi, Amritpal Singh, Naseema Gangat, et al.
Blood Cancer Journal
|
June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
Mayo Clinic Proceedings
|
March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Haematologica
|
February 16, 2023
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
Maymona G Abdelmagid, Aref Al-Kali, Kebede H Begna, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Haematologica
|
December 15, 2022
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm
Naseema Gangat, Rimal Ilyas, Kristen McCullough, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2016
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 9